Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index; 36 of the 74 sources its claims cite were checked for support.
Abstract
Despite its abundance in the environment, iron is poorly bioavailable and subject to strict conservation and internal recycling by most organisms. In vertebrates, the stability of iron concentration in plasma and extracellular fluid, and the total body iron content are maintained by the interaction of the iron-regulatory peptide hormone hepcidin with its receptor and cellular iron exporter ferroportin (SLC40a1). Ferroportin exports iron from duodenal enterocytes that absorb dietary iron, from iron-recycling macrophages in the spleen and the liver, and from iron-storing hepatocytes. Hepcidin blocks iron export through ferroportin, causing hypoferremia. During iron deficiency or after hemorrhage, hepcidin decreases to allow iron delivery to plasma through ferroportin, thus promoting compensatory erythropoiesis. As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroportin to blood plasma, thus limiting iron availability to invading microbes. Genetic diseases that decrease hepcidin synthesis or disrupt hepcidin binding to ferroportin cause the iron overload disorder hereditary hemochromatosis. The opposite phenotype, iron restriction or iron deficiency, can result from genetic or inflammatory overproduction of hepcidin.
Overview
CoChat Summary
TL;DR
The review describes how hepcidin binding to ferroportin controls systemic iron homeostasis by blocking cellular iron export, thereby regulating plasma iron, erythropoiesis, and host defense. Dysregulation of this axis causes iron overload such as hereditary hemochromatosis or iron-restrictive anemias, making it a therapeutic target.
Key findings
- Hepcidin, a 25-amino-acid peptide (MW 2.8 kD) present at approximately 2–20 nM in healthy humans, binds ferroportin (SLC40A1; 571 amino acids, ~65–70 kD) and inhibits iron export by occluding the open-outward conformation and inducing endocytosis/degradation.
- Ferroportin exports iron from duodenal enterocytes, iron-recycling macrophages, and hepatocytes; adult humans have total body iron of approximately 3–4 g with daily losses of only 1–2 mg, while plasma transferrin holds only 2–3 mg of iron but delivers 20–25 mg/day.
- The erythron contains approximately 2–3 g of iron, about 2/3–3/4 of total body iron; hepatocyte stores contain up to 1 g, the spleen normally about 0.05 g, and other tissues about 0.3 g.
- Loss of hepcidin or disrupted hepcidin binding to ferroportin causes hereditary hemochromatosis; excessive hepcidin, such as from TMPRSS6 mutations, causes iron-refractory iron deficiency anemia (IRIDA), and inflammatory hepcidin increases produce hypoferremia and nutritional immunity.
Methods
- Narrative review synthesizing published literature; no primary experimental design, sample, or statistical analysis is reported.
- The text integrates structural, genetic, physiological, and clinical evidence from cited studies, including mouse models and human disease examples.
- Not stated in the paper: systematic search strategy, inclusion/exclusion criteria, or data-extraction methods.
Limitations
- The paper states unresolved issues: how ferroportin’s two divalent metal-binding sites mediate export is not clear; the energetics of iron export are not well characterized; functional consequences of tissue-specific ferroportin glycosylation are not understood; the quantitative contribution of hepcidin clearance mechanisms is unknown; and the physiological role of microRNA regulation is uncertain.
- Evident from the text: as a narrative review, it lacks a described systematic search or formal quality assessment, so conclusions depend on selected cited literature.
- Not stated in the paper: an explicit limitations section or discussion of publication bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].](https://figures.cochat.ai/paper-figures/a8d0b48e97e349ad9b7b164106596b50/hepcidin-ferroportin-interaction-controls-systemic-iron-homeostasis-figure-3.jpg)


Verification
Claims the paper makes
31 Valid · 2 Not valid · 28 Not checked · 21 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Because iron is exported against the force exerted by the transmembrane electric field, and there is no evidence of direct coupling of the transport to ATP hydrolysis, the export of iron is likely facilitated by the coupled “downhill” transport of another ion or small molecule [13].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 4. Ferroportin Structure
What the sources say
- Disputedcites [13] Deshpande, 2018, Calcium is an essential cofactor for metal efflux by the ferroportin transporter family, Nat. Commun. sourceExperimental — accuracy not yet measured
The Results section reports that iron efflux does not depend on a transmembrane H+ gradient or Na+, and experiments do not support Fe2+/Ca2+ antiport. The paper instead identifies extracellular Ca2+ as a cofactor that activates ferroportin without being transported. These findings run contrary to the proposed downhill-coupled transport mechanism. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Efficient filtration of hepcidin in the glomerulus is facilitated by the relatively low fraction of hepcidin that is bound by plasma protein, estimated at about 40% [28].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 6. Hepcidin Synthesis and Elimination
What the sources say
- Partly supportedcites [28] Diepeveen, L.E., Laarakkers, C.M., Peters, H.P.E., van Herwaarden, A.E., Groenewoud, H., IntHout, J., Wetzels, J.F., van Swelm, R.P.L., and Swinkels, D.W. (2019). Unraveling hepcidin plasma protein binding: Evidence from peritoneal equilibration testing. Pharmaceuticals, 12. sourceExperimental — accuracy not yet measured
The Abstract reports a hepcidin protein-bound fraction of 40% (±23%), and the Discussion says hepcidin is not predominantly bound and is rapidly excreted by the kidneys. The study used peritoneal dialysis in patients with end-stage renal disease; it does not establish that low protein binding facilitates efficient filtration in the glomerulus. (LLM, conf=0.86)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study [21] provide convincing evidence that Rnf217 is an important E3 ubiquitin ligase that triggers the degradation of ferroportin in response to hepcidin binding.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Supportedcites [21] Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., and Song, Z. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. source
The Introduction states that hepcidin binds ferroportin and induces its internalization and degradation. The Results report that RNF217’s E3 ubiquitin ligase activity is required for ferroportin degradation and that hepcidin-mediated degradation is at least partially RNF217-dependent in mice. The paper also notes that RNF217 can promote degradation without added hepcidin in vitro, so the response to hepcidin is not its only observed mode of action. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, duodenal iron absorption increases several-fold after blood loss or exposure to hypoxia, or in response to iron deficiency.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 2. Iron Compartments and Flows
What the sources say
- Partly supportedcites [3] Finch, 1994, Regulators of iron balance in humans, Blood sourceExperimental — accuracy not yet measured
The Store Regulator (p. 2) says absorption is high when iron stores are depleted, and The Erythroid-Regulator (p. 3) reports increased absorption after phlebotomy and in iron-deficiency anemia. The latter section links hypoxia to erythropoietin release, but does not report a several-fold rise in duodenal absorption after hypoxia exposure; it also does not establish a several-fold increase for each condition in the claim. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Partly supportedcites [14] Billesbolle, 2020, Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms, Nature sourceExperimental — accuracy not yet measured
The hepcidin-binding section (p. 6) supports the role of a C-domain metal site: iron greatly increases hepcidin affinity, and mutations at that site weaken binding. But the cited paper identifies the coordinating cysteine as C326, not C325; C325 is not the cysteine named in this claim. The structure directly shows cobalt, an iron mimetic, at the site. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
44 more claims · 19 with their cited sources checked
Create a free account to see all 82 claims and to verify the 10 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 3
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
“the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 7. Evidence for Exclusivity of the Hepcidin-Ferroportin Ligand-Receptor Dyad
“the essential conserved amino acid at the ferroportin binding site for hepcidin, C326 (human numbering)”
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 3×
“The flow of iron out of the cells is controlled by hepcidin through two known mechanisms: occlusion of the open-outward conformation of ferroportin by hepcidin [17], and hepcidin-induced endocytosis and degradation of ferroportin [4].”
BackgroundSelf-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“Infection and inflammation induce hepcidin, predominantly through the effects of the cytokine interleukin-6 (IL-6) [52], and increased concentrations of hepcidin then inhibit ferroportin activity, leading to depletion of iron in plasma and extracellular fluid (hypoferremia).”
BackgroundSelf-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundSelf-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · cited 1×
“During pregnancy, ferroportin is very highly expressed on the basal surface of syncytiotrophoblast in the placenta [7,50], where it plays an indispensable role in iron transfer to the fetus.”
BackgroundMcKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Zimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405 · cited 1×
“Iron deficiency, iron deficiency anemia [65] and anemia of inflammation [66] are very common disorders affecting a large portion of the population.”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Self-citationImmunoassay for human serum hepcidin
Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood · doi:10.1182/blood-2008-02-139915 · Cited by 688 · cited 2×
“8 kD) is synthesized by hepatocytes and secreted nto blood plasma, with concentrations in healthy humans ranging from approximately 2–20 nM [5,6], aroun hundred-fold higher than the concentration of the similarlysized eptide hormones i sulin glucagon or parathyroi ormone.”
BackgroundSelf-citationMutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydınok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.130 · Cited by 675
Ganz, T. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1804281 · Cited by 589
Self-citationThe serine protease TMPRSS6 is required to sense iron deficiency
Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. Y., et al. (2008) · Science · doi:10.1126/science.1157121 · Cited by 578 · cited 1×
“Loss-of-function mutations in the negative regulator of hepcidin transcription, the transmembrane serine protease TMPRSS6 (also called matriptase 2), in mice or humans cause a disease “iron-refractory iron deficiency anemia” (IRIDA) where hepcidin is excessive despite severe iron deficiency [63,64].”
BackgroundRegulators of iron balance in humans [see comments]
Finch, C. (1994) · Blood · doi:10.1182/blood.v84.6.1697.1697 · Cited by 455 · cited 1×
“These observations provided early evidence that the absorption and tissue distribution of iron must be subject to endocrine regulation [3].”
BackgroundLiver iron sensing and body iron homeostasis
Wang, C.-Y., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood-2018-06-815894 · Cited by 360 · cited 1×
“The mechanisms were reviewed in recent publications [25,26] and will not be discussed here.”
BackgroundStructure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms
Billesbølle, C. B., Azumaya, C. M., Kretsch, R. C., Powers, A. S., Gonen, S., Schneider, S., Arvedson, T., Dror, R. O., Cheng, Y., & Manglik, A. (2020) · Nature · doi:10.1038/s41586-020-2668-z · Cited by 344 · cited 3×
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
BackgroundHepcidin-Induced Endocytosis of Ferroportin Is Dependent on Ferroportin Ubiquitination
Qiao, B., Sugianto, P., Fung, E., del-Castillo-Rueda, A., Moran-Jimenez, M.-J., Ganz, T., & Nemeth, E. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.018 · Cited by 334 · cited 2×
“It appears to require hepcidin-induced conformational change in ferroportin that triggers the ubiquitination of the lysine-rich cytoplasmic segment connecting the two 6-helix domains of ferroportin [19,20].”
BackgroundSelf-citationAschemeyer, S., Qiao, B., Stefanova, D., Valore, E. V., Sek, A. C., Ruwe, T. A., Vieth, K. R., Jung, G., Casu, C., Rivella, S., et al. (2018) · Blood · doi:10.1182/blood-2017-05-786590 · Cited by 325 · cited 1×
“The flow of iron out of the cells is controlled by hepcidin through two known mechanisms: occlusion of the open-outward conformation of ferroportin by hepcidin [17], and hepcidin-induced endocytosis and degradation of ferroportin [4].”
BackgroundSelf-citationRivera, S., Nemeth, E., Gabayan, V., Lopez, M. A., Farshidi, D., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2005-04-1766 · Cited by 308 · cited 2×
“membrane [27], followed by reuptake and degradation of filtered hepcidin in the proximal tubule, utilizing a generic mechanism for recycling the amino acid content of filtered proteins.”
BackgroundSelf-citationMarro, S., Chiabrando, D., Messana, E., Stolte, J., Turco, E., Tolosano, E., & Muckenthaler, M. U. (2010) · Haematologica · doi:10.3324/haematol.2009.020123 · Cited by 297 · cited 4×
“Bach1 is replaced by the transcriptional inducer Nrf2 which is stabilized by heme, translocated into the nucleus, and stimulates the transcription of the ferroportin gene and other genes involved in the recycling of heme to iron [36,41].”
BackgroundInfluentialDelaby, C., Pilard, N., Gonçalves, A. S., Beaumont, C., & Canonne-Hergaux, F. (2005) · Blood · doi:10.1182/blood-2005-06-2398 · Cited by 283 · cited 1×
“iron, ferroportin mRNA and protein are increased, presumably because of oxidative stress causing Nrf2-mediated induction of ferroportin [42,43].”
BackgroundZhang, D.-L., Hughes, R. M., Ollivierre-Wilson, H., Ghosh, M. C., & Rouault, T. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.006 · Cited by 281 · cited 5×
“Sci. 2021, 22, 6493 7 of 13 The IRE-IRP system functions in most cells to coordinate ferroportin translation with intracellular iron levels.”
BackgroundInfluentialPreza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M. A., Sharma, S., Waring, A., Ganz, T., & Nemeth, E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57693 · Cited by 234 · cited 2×
“How the new structural model accom od tes other hepcidin agonists ranging from minihepcidin peptides [23] to small molecules [24] remains to be determined.”
BackgroundSelf-citationArezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P. A., Ganz, T., Nemeth, E., & Bulut, Y. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.12.001 · Cited by 227 · cited 1×
“Hypoferremia has long been suspected of having a host defense function but direct evidence for this is quite recent [53].”
BackgroundSelf-citationNon-transferrin-bound iron transporters
Knutson, M. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.413 · Cited by 221 · cited 1×
“In affected patients who are not treated, NTBI is taken up avidly through alternative iron transporters [62] in the liver, pancreas, heart and endocrine glands, causing progressive tissue injury, organ failure, and even premature death.”
BackgroundSchwartz, A. J., Das, N. K., Ramakrishnan, S. K., Jain, C., Jurkovic, M. T., Wu, J., Nemeth, E., Lakhal-Littleton, S., Colacino, J. A., & Shah, Y. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122359 · Cited by 203 · cited 3×
“HIF2α [38] transcriptional enterocyte ↓ cellular iron = ↑ FPN May induce ferroportin mRNA in enterocytes during low hepcidin states”
BackgroundInfluentialSelf-citationEffects of maternal iron status on placental and fetal iron homeostasis
Sangkhae, V., Fisher, A. L., Wong, S., Koenig, M. D., Tussing-Humphreys, L., Chu, A., Lelić, M., Ganz, T., & Nemeth, E. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127341 · Cited by 198 · cited 3×
“Interestingly, in normal pregnancy, fetal hepcidin concentrations are very low in mice [50] and do not appear to contribute to baseline iron homeostasis or affect iron transport through placental ferroportin.”
BackgroundHepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia
Rivera, S., Liu, L., Nemeth, E., Gabayan, V., Sorensen, O. E., & Ganz, T. (2005) · Blood · doi:10.1182/blood-2004-08-3375 · Cited by 196 · cited 1×
“Although hepcidin peptide injected into mice is cleared from blood circulation within minutes, its plasma iron lowering effect lasts for 24–48 h, supporting the importance of the endocytic mechanism for ferroportin physiology [18].”
BackgroundSelf-citationAn essential cell-autonomous role for hepcidin in cardiac iron homeostasis
Lakhal-Littleton, S., Wolna, M., Chung, Y. J., Christian, H. C., Heather, L. C., Brescia, M., Ball, V., Diaz, R., Santos, A., Biggs, D., et al. (2016) · eLife · doi:10.7554/elife.19804 · Cited by 184 · cited 2×
“Rather, hepcidin acts as an autocrine or paracrine regulator of ferroportin that may protect tissues from loss of iron through ferroportin and extreme iron deficiency when systemic hepcidin concentrations are very low [47].”
BackgroundA novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia
Guida, C., Altamura, S., Klein, F. A., Galy, B., Boutros, M., Ulmer, A. J., Hentze, M. W., & Muckenthaler, M. U. (2015) · Blood · doi:10.1182/blood-2014-08-595256 · Cited by 173 · cited 3×
“TLR [34] transcriptional macrophage Ligands ↓ FPN Unclear how much this mechanism contributes to responses to infections”
BackgroundInfluentialIron export through the transporter ferroportin 1 is modulated by the iron chaperone PCBP2
Yanatori, I., Richardson, D. R., Imada, K., & Kishi, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721936 · Cited by 170 · cited 1×
“Current evidence indicates that cytoplasmic iron is predominantly present as a complex of ferrous iron with reduced glutathione (summarized in [15]), and that the complex of ferrous iron and reduced glutathione may be delivered to ferroportin via the cytoplasmic iron chaperone PCBP2 [16].”
BackgroundErythroferrone structure, function, and physiology: Iron homeostasis and beyond
Srole, D. N., & Ganz, T. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30247 · Cited by 155 · cited 1×
“The mechanisms were reviewed in recent publications [25,26] and will not be discussed here.”
BackgroundSelf-citationErythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk
Zhang, D.-L., Wu, J., Shah, B. N., Greutélaers, K. C., Ghosh, M. C., Ollivierre, H., Su, X.-Z., Thuma, P. E., Bedu-Addo, G., Mockenhaupt, F. P., et al. (2018) · Science · doi:10.1126/science.aal2022 · Cited by 150 · cited 1×
“The importance of these mechanism is illustrated by the adverse consequences of erythroid-specific disruption of the ferroportin gene in mice, which suffer from mild hemolytic anemia caused by increased sensitivity of erythrocytes to hemolytic stress [45,46].”
BackgroundRoss, S. L., Tran, L., Winters, A., Lee, K.-J., Plewa, C., Foltz, I., King, C., Miranda, L. P., Allen, J., Beckman, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.017 · Cited by 145 · cited 2×
“It appears to require hepcidin-induced conformational change in ferroportin that triggers the ubiquitination of the lysine-rich cytoplasmic segment connecting the two 6-helix domains of ferroportin [19,20].”
BackgroundSelf-citationStefanova, D., Raychev, A., Arezes, J., Ruchala, P., Gabayan, V., Skurnik, M., Dillon, B. J., Horwitz, M. A., Ganz, T., Bulut, Y., et al. (2017) · Blood · doi:10.1182/blood-2017-03-772715 · Cited by 145 · cited 5×
“In affected patients who are not treated, NTBI is taken up avidly through alternative iron transporters [62] in the liver, pancreas, heart and endocrine glands, causing progressive tissue injury, organ failure, and even premature death.”
BackgroundInfluentialSelf-citationDendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing
Bessman, N. J., Mathieu, J. R. R., Renassia, C., Zhou, L., Fung, T. C., Fernandez, K. C., Austin, C., Moeller, J. B., Zumerle, S., Louis, S., et al. (2020) · Science · doi:10.1126/science.aau6481 · Cited by 145 · cited 1×
“In a mouse model of colitis, the hepcidin-ferroportin interaction in the intestine was shown to be important for mucosal healing [49].”
BackgroundFillet, G., Beguin, Y., & Baldelli, L. (1989) · Blood · doi:10.1182/blood.v74.2.844.844 · Cited by 144
Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin
Sangokoya, C., Doss, J. F., & Chi, J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003408 · Cited by 142 · cited 2×
“There is evidence that microRNAs such as miR-485-3p, miR-20a and miR-20b, can posttranscriptionally downregulate ferroportin but the physiological role of this mechanism is uncertain [37,39,40].”
BackgroundJiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., Song, Z., et al. (2021) · Blood · doi:10.1182/blood.2020008986 · Cited by 138
Mitchell, C. J., Shawki, A., Ganz, T., Nemeth, E., & Mackenzie, B. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00348.2013 · Cited by 132 · cited 1×
“The exported species is almost certainly ferrous iron [12] but the energetics of iron export is not yet well characterized.”
BackgroundSelf-citationComparative studies of duodenal and macrophage ferroportin proteins
Canonne-Hergaux, F., Donovan, A., Delaby, C., Wang, H.-J., & Gros, P. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00227.2005 · Cited by 124 · cited 1×
“The variation in molecular mass is likely caused by tissue-specific glycosylation but the functional consequences of the glycosylation differences between the forms purified from the duodenal enterocytes, hepatocytes and macrophages are not yet understood [10].”
BackgroundTaniguchi, R., Kato, H. E., Font, J., Deshpande, C. N., Wada, M., Ito, K., Ishitani, R., Jormakka, M., & Nureki, O. (2015) · Nature Communications · doi:10.1038/ncomms9545 · Cited by 120 · cited 2×
“The remarkable feat of structural characterization of a ferroportin from the bacterium Bdellovibrio bacteriovorus in both open-outward and open-inward conformations [11] represents strong support for such a model.”
BackgroundAltamura, S., Kessler, R., Gröne, H.-J., Gretz, N., Hentze, M. W., Galy, B., & Muckenthaler, M. U. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.007 · Cited by 119 · cited 1×
“Consistent with the dyadic relationship between hepcidin and ferroportin, the isosteric C326S mutation in mice and humans, which causes complete loss of binding of hepcidin to ferroportin, phenocopies severe hepcidin deficiency [33].”
BackgroundHepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts
Zhang, D.-L., Senecal, T., Ghosh, M. C., Ollivierre-Wilson, H., Tu, T., & Rouault, T. A. (2011) · Blood · doi:10.1182/blood-2011-01-330241 · Cited by 113 · cited 1×
“In erythroblasts, it may release unobligated iron and here it is subject to hepcidin regulation [44].”
BackgroundmiR-20a regulates expression of the iron exporter ferroportin in lung cancer
Babu, K. R., & Muckenthaler, M. U. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1362-3 · Cited by 113 · cited 2×
“There is evidence that microRNAs such as miR-485-3p, miR-20a and miR-20b, can posttranscriptionally downregulate ferroportin but the physiological role of this mechanism is uncertain [37,39,40].”
BackgroundReduction of serum hepcidin by hemodialysis in pediatric and adult patients
Zaritsky, J., Young, B., Gales, B., Wang, H.-J., Rastogi, A., Westerman, M., Nemeth, E., Ganz, T., & Salusky, I. B. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08161109 · Cited by 107 · cited 1×
“In support of the important role of the kidneys in hepcidin removal, serum hepcidin concentrations are very high in patients with chronic renal failure, but are effectively lowered by hemodialysis [29].”
BackgroundSelf-citationZhang, D.-L., Ghosh, M. C., Ollivierre, H., Li, Y., & Rouault, T. A. (2018) · Blood · doi:10.1182/blood-2018-04-842997 · Cited by 107 · cited 1×
“The importance of these mechanism is illustrated by the adverse consequences of erythroid-specific disruption of the ferroportin gene in mice, which suffer from mild hemolytic anemia caused by increased sensitivity of erythrocytes to hemolytic stress [45,46].”
BackgroundManagement versus miscues in the cytosolic labile iron pool: The varied functions of iron chaperones
Philpott, C. C., Patel, S. J., & Protchenko, O. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118830 · Cited by 105 · cited 1×
“Current evidence indicates that cytoplasmic iron is predominantly present as a complex of ferrous iron with reduced glutathione (summarized in [15]), and that the complex of ferrous iron and reduced glutathione may be delivered to ferroportin via the cytoplasmic iron chaperone PCBP2 [16].”
BackgroundTroutt, J. S., Rudling, M., Persson, L., Ståhle, L., Angelin, B., Butterfield, A. M., Schade, A. E., Cao, G., & Konrad, R. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.186866 · Cited by 100 · cited 2×
“8 kD) is synthesized by hepatocytes and secreted nto blood plasma, with concentrations in healthy humans ranging from approximately 2–20 nM [5,6], aroun hundred-fold higher than the concentration of the similarlysized eptide hormones i sulin glucagon or parathyroi ormone.”
BackgroundOral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia
Manolova, V., Nyffenegger, N., Flace, A., Altermatt, P., Varol, A., Doucerain, C., Sundstrom, H., & Dürrenberger, F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129382 · Cited by 98 · cited 2×
“How the new structural model accom od tes other hepcidin agonists ranging from minihepcidin peptides [23] to small molecules [24] remains to be determined.”
BackgroundHepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia
Michels, K. R., Zhang, Z., Bettina, A. M., Cagnina, R. E., Stefanova, D., Burdick, M. D., Vaulont, S., Nemeth, E., Ganz, T., & Mehrad, B. (2017) · JCI Insight · doi:10.1172/jci.insight.92002 · Cited by 93
Self-citationRecycling Iron in Normal and Pathological States
Beaumont, C., & Delaby, C. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.004 · Cited by 84 · cited 1×
“Bach1 is replaced by the transcriptional inducer Nrf2 which is stabilized by heme, translocated into the nucleus, and stimulates the transcription of the ferroportin gene and other genes involved in the recycling of heme to iron [36,41].”
BackgroundStefanova, D., Raychev, A., Deville, J., Humphries, R., Campeau, S., Ruchala, P., Nemeth, E., Ganz, T., & Bulut, Y. (2018) · Infection and Immunity · doi:10.1128/iai.00253-18 · Cited by 68
Self-citationThe Repair of Skeletal Muscle Requires Iron Recycling through Macrophage Ferroportin
Corna, G., Caserta, I., Monno, A., Apostoli, P., Manfredi, A. A., Camaschella, C., & Rovere-Querini, P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501417 · Cited by 63 · cited 1×
“Macrophage ferroportin also plays an important role in iron recycling after muscle injury [48].”
BackgroundCalcium is an essential cofactor for metal efflux by the ferroportin transporter family
Deshpande, C. N., Ruwe, T. A., Shawki, A., Xin, V., Vieth, K. R., Valore, E. V., Qiao, B., Ganz, T., Nemeth, E., Mackenzie, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05446-4 · Cited by 57 · cited 3×
“Because iron is exported against the force exerted by the transmembrane electric field, and there is no evidence of direct coupling of the transport to ATP hydrolysis, the export of iron is likely facilitated by the coupled “downhill” transport of another ion or small molecule [13].”
BackgroundSelf-citationCellular Catabolism of the Iron-Regulatory Peptide Hormone Hepcidin
Preza, G. C., Pinon, R., Ganz, T., & Nemeth, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058934 · Cited by 56 · cited 1×
“The second mechanism of hepcidin clearance depends on the endocytosis of the hepcidin-ferroportin complexes by the cells that express high concentrations of ferroportin [30,31].”
BackgroundSelf-citationMorgan, E. H., & Walters, M. N. (1963) · Journal of Clinical Pathology · doi:10.1136/jcp.16.2.101 · Cited by 56
Genetic hemochromatosis: Pathophysiology, diagnostic and therapeutic management
Brissot, P., Cavey, T., Ropert, M., Guggenbuhl, P., & Loréal, O. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.05.037 · Cited by 55
Aydemir, F., Jenkitkasemwong, S., Gulec, S., & Knutson, M. D. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.094052 · Cited by 49 · cited 1×
“iron, ferroportin mRNA and protein are increased, presumably because of oxidative stress causing Nrf2-mediated induction of ferroportin [42,43].”
BackgroundFetal liver hepcidin secures iron stores in utero
Kämmerer, L., Mohammad, G., Wolna, M., Robbins, P. A., & Lakhal-Littleton, S. (2020) · Blood · doi:10.1182/blood.2019003907 · Cited by 38 · cited 1×
“However, fetal hepatic production of hepcidin may be sufficient to act on fetal hepatic ferroportin in an autocrine/paracrine manner to retain iron in the fetal liver [51] where it is used for fetal erythropoiesis until erythropoiesis transitions to the marrow, close to birth.”
BackgroundMouse Models of Anemia of Cancer
Kim, A., Rivera, S., Shprung, D., Limbrick, D., Gabayan, V., Nemeth, E., & Ganz, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093283 · Cited by 35 · cited 1×
“The second mechanism of hepcidin clearance depends on the endocytosis of the hepcidin-ferroportin complexes by the cells that express high concentrations of ferroportin [30,31].”
BackgroundSelf-citationPetzer, V., Wermke, M., Tymoszuk, P., Wolf, D., Seifert, M., Ovaçin, R., Berger, S., Orth-Höller, D., Loacker, L., Weiss, G., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000043 · Cited by 22
MiR-20b Down-Regulates Intestinal Ferroportin Expression In Vitro and In Vivo
Jiang, S., Fang, X., Liu, M., Ni, Y., Ma, W., & Zhao, R. (2019) · Cells · doi:10.3390/cells8101135 · Cited by 22 · cited 2×
“There is evidence that microRNAs such as miR-485-3p, miR-20a and miR-20b, can posttranscriptionally downregulate ferroportin but the physiological role of this mechanism is uncertain [37,39,40].”
BackgroundChondrostean sturgeon hepcidin: An evolutionary link between teleost and tetrapod hepcidins
Kim, C., Kim, E. J., & Nam, Y. K. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.02.045 · Cited by 21 · cited 2×
“A second hepcidin gene is found in some v rt brates, mostly fish, but is not invol ed in iron regulation, and is hypothesized to have another function, perhaps as an a timicrobial pe tide [32].”
BackgroundThe role of cellular iron deficiency in controlling iron export
Link, C. J., Knopf, J. D., Marques, O., Lemberg, M. K., & Muckenthaler, M. U. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129829 · Cited by 15 · cited 2×
“One indication that this mechanism may have a physiological effect is t e recently reported inhibition of hepcidin-induced ferr portin degradation by the intracellular iron chelator deferiprone but not by the ext acellularly acting chela or d feroxamin [22].”
BackgroundUnraveling Hepcidin Plasma Protein Binding: Evidence from Peritoneal Equilibration Testing
Diepeveen, L. E., Laarakkers, C. M., Peters, H. P. E., van Herwaarden, A. E., Groenewoud, H., IntHout, J., Wetzels, J. F., van Swelm, R. P. L., & Swinkels, D. W. (2019) · Pharmaceuticals · doi:10.3390/ph12030123 · Cited by 11
Cited by
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z.-M., Yi, X., Wei, X., & Jiang, D.-S. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05716-0 · Cited by 567
“As the core node that modulates the distribution of iron in different organs, hepcidin is synthesized and secreted by hepatocytes and can hinder intracellular iron export by degrading ferroportin [132, 133].”
BackgroundIron imbalance in neurodegeneration
Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02399-z · Cited by 203
“As demonstrated for systemic iron absorption [6], several studies have reported the importance of hepcidin/ferroportin (Hep/Fpn) interactions [48] in regulating these exchanges between brain tissue cells [49].”
BackgroundIron deficiency and cardiovascular disease
Savarese, G., von Haehling, S., Butler, J., Cleland, J. G. F., Ponikowski, P., & Anker, S. D. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac569 · Cited by 200
“Inflammation leads to an increased release of hepcidin, a liverexpressed type II acute phase protein and a major player in iron homeostasis.(3) Hepcidin regulates the degradation of ferroportin, a transmembrane protein which transports iron absorbed after dietary intake from the inside of the mucosal cells in the smal…”
BackgroundIron and the pathophysiology of diabetes
Harrison, A. V., Lorenzo, F. R., & McClain, D. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022522-102832 · Cited by 161
“While necessary for metabolism, iron is also a potent oxidant, and complex systems to regulate its uptake, storage, and bioavailability also evolved (3,4) (Figure 1).”
BackgroundIron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets
Sawicki, K. T., Jesus, A. D., & Ardehali, H. (2023) · Circulation Research · doi:10.1161/circresaha.122.321667 · Cited by 179
Metadata
- Authors
- Nemeth, E., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-17
- Volume
- 22
- Issue
- 12
- Pages
- 6493
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8235187
- OpenAlex
- W3172506357
- Semantic Scholar
- 8da9eb7ee1579f5db94cd40eca5fde949bb5967c
- Cited by
- 540
- References
- 69
- Citations by year
- 2026: 101 · 2025: 143 · 2024: 107 · 2023: 110 · 2022: 71 · 2021: 7
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD096863)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hepcidin, ferroportin, SLC40A1, iron homeostasis, iron export, hypoferremia, compensatory erythropoiesis, iron deficiency, hereditary hemochromatosis, inflammation, infection, iron overload, iron recycling, macrophages, hepatocytes
- MeSH terms
- Ferroportin, Animals, Biological Transport, Disease Susceptibility, Homeostasis, Humans, Iron, Ligands, Protein Binding, Tissue Distribution, Signal Transduction, Autocrine Communication, Paracrine Communication, Cation Transport Proteins, Metabolic Networks and Pathways, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.